Inside Therapeutics (InsideTx)
Inside Therapeutics is a nanomedicine company founded in 2022, specializing in nanoparticle manufacturing and RNA-lipid nanoparticle (LNP) formulation. Their mission is to provide tools for seamless scalability in nanoparticle-based drug development, unlocking the potential of RNA-LNP vaccines and therapeutics. They offer the TAMARA system, a nanoparticle & RNA-LNP formulation system designed for rapid and user-friendly formulation, handling volumes from 200 µL to 30 mL, with maximized yield and precise control over nanoparticle characteristics. Their patented technology addresses bottlenecks in the manufacturing process, minimizing screening costs, ensuring scalability, and enabling large-scale continuous production. Inside Therapeutics has four patents and is backed by investors like Newfund and Skalepark, with offices in Angoulême, Bordeaux, and Paris, France. They have been labeled 'Deeptech' by BPI France and have a team of 20 employees.
Inside Therapeutics (InsideTx)
Inside Therapeutics is a nanomedicine company founded in 2022, specializing in nanoparticle manufacturing and RNA-lipid nanoparticle (LNP) formulation. Their mission is to provide tools for seamless scalability in nanoparticle-based drug development, unlocking the potential of RNA-LNP vaccines and therapeutics. They offer the TAMARA system, a nanoparticle & RNA-LNP formulation system designed for rapid and user-friendly formulation, handling volumes from 200 µL to 30 mL, with maximized yield and precise control over nanoparticle characteristics. Their patented technology addresses bottlenecks in the manufacturing process, minimizing screening costs, ensuring scalability, and enabling large-scale continuous production. Inside Therapeutics has four patents and is backed by investors like Newfund and Skalepark, with offices in Angoulême, Bordeaux, and Paris, France. They have been labeled 'Deeptech' by BPI France and have a team of 20 employees.